P458
Cardiac fibroblasts as inflammatory supporter cells trigger cardiac inflammation in heart failure - Influence of Heart Rate on Pathophysiological Fibroblast Activation

Cardiovascular Research

23 April 2018

Organised by:

Read full article

Contributors

D Lindner

D Lindner

Author

S Hinrichs

S Hinrichs

Author

J Schoen

J Schoen

Author

F Gotzhein

F Gotzhein

Author

M Scwarzl

M Scwarzl

Author

S Blankenberg

S Blankenberg

Author

U Voelker

U Voelker

Author

E Hammer

E Hammer

Author

D Wstermann

D Wstermann

Author

You may be interested in

Congress Presentation

Activated myofibroblasts promote cardiac hypertrophy and systolic dysfunction independently of cardiac fibrosis in experimental autoimmune myocarditis

27 August 2021

Congress Presentation

Inflammation and arterial hypertension are the main risk factors occurrence of AF in patients with heart failure patients with preserved ejection fraction (retrospective study)

12 May 2024

Congress Session

Therapeutic modulation of the immune system in heart failure

18 May 2025

Congress Presentation

Initial phase of anthracycline cardiotoxicity involves metabolic switch and activation of cardiac fibroblasts

28 August 2023

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources